Results 121 to 130 of about 42,935 (312)
Review: nicotine replacement therapy as assisted "reduction-to-stop" reduces smoking and sustains abstinence in smokers [PDF]
, 2009 Brian A. Primack
openalex +1 more source
The changing face of nicotine use in England: Age‐specific annual trends, 2014 to 2024
Addiction, EarlyView.Abstract Aims To examine age‐specific trends in patterns of nicotine use in England between 2014 and 2024, including types of products used, exclusive and dual use of smoking and vaping, smoking frequency and the smoking history of those who vape.
Sarah E. Jackson +6 more
wiley +1 more source
E-cigarettes for the management of nicotine addiction
Substance Abuse and Rehabilitation, 2016 Oliver Knight-West, Christopher Bullen The National Institute for Health Innovation, School of Population Health, The University of Auckland, Auckland, New Zealand Abstract: In this review, we discuss current evidence on electronic cigarettes (ECs),
Knight-West O, Bullen C
doaj
Addiction, EarlyView.Abstract Background and aims Evidence for motivational interviewing for smoking cessation is weak, with limited data on long‐term abstinence rates. This trial aimed to evaluate the effect of in‐hospital motivational interviewing‐based smoking cessation counselling combined with proactive referral to community‐based follow‐up on 6‐ and 12‐month ...
Karin Pleym +8 more
wiley +1 more source
Correction to: Should nicotine replacement therapy be provided free of charge? [PDF]
, 2023 openalex +1 more source
Smoking Cessation, Counseling & Therapy Program Helps Patients Kick the Habit [PDF]
, 2016 The Department of Surgery’s Smoking Cessation, Counseling & Therapy (SCCT) Program offers evidencebased strategies for quitting smoking, including one-on-one counseling, nicotine replacement therapy and prescription medication, such as Chantix and ...
core +1 more source
Addiction‐related problems in Japan: A regional perspective
Addiction, EarlyView.Abstract Japan's addiction landscape appears paradoxical. The lifetime use of illicit drugs is among the lowest in Organisation for Economic Cooperation and Development countries, but harm from alcohol, tobacco, and gambling ranks among the world's highest.
Soichiro Ide +19 more
wiley +1 more source
INDUSTRY FUNDING AND PLACEBO QUIT RATE IN CLINICAL TRIALS OF NICOTINE REPLACEMENT THERAPY: A COMMENTARY ON ETTER ET AL. (2007) [PDF]
, 2010 NATASHA M. P. GREENE +3 more
openalex +1 more source
Asia-Pacific Journal of Clinical Oncology, EarlyView.Lung cancer remains Australia's leading cause of cancer death. With new screening and evolving therapies, equitable access and workforce readiness are essential. This review discusses current and emerging treatments for NSCLC in Australia, clinical trials underway, and future directions in delivering optimal, accessible care nationwide.
Lauren Julia Brown +7 more
wiley +1 more source
Artificial Organs, EarlyView.Multicenter real‐world cohort (n = 327) comparing LVADs: HeartMate 3 (HM3), HeartMate II (HMII), and HeartWare (HVAD). HM3 showed superior long‐term survival versus legacy devices, driven by fewer hemocompatibility‐related adverse events, especially pump thrombosis and ischemic stroke, while major bleeding was similar across devices.
Hamza H. H. Ben Nasir +9 more
wiley +1 more source